Y. Tanaka

Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann–Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease

Y. Tanaka, Yusei Yamada, Yoichi Ishitsuka et al. · Biological and Pharmaceutical Bulletin · 2015 · 85 citations · Full text

Subcutaneous Injection, Pharmacotherapy, Pharmacokinetic Analysis +17

Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice

Ken‐ichiro Tanaka, Y. Tanaka, Takushi Namba et al. · Biochemical Pharmacology · 2010 · 80 citations

Inflammation, Fibrosis, Bleomycin-induced Pulmonary Fibrosis +10

Activation of sympathetic outflow by recombinant human interleukin-1 beta in conscious rats

H. Kannan, Y. Tanaka, Takato Kunitake et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1996 · 78 citations

Hypertension, Immunology, Renal Inflammation +20

The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice

Y. Tanaka, Yoichi Ishitsuka, Marina Hayasaka et al. · Pharmacological Research · 2015 · 51 citations

Inflammation, Fibrosis, Antifibrotic Therapy +11

Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia

Miho Kobayashi, C Yumiba, Yoshihide Kawaguchi et al. · Blood · 1990 · 42 citations · Full text